Page 65 - OR-1-1

doi: 10.1002/adma.202309875 135. LeSavage BL, Suhar RA, Broguiere N, Lutolf MP,
Heilshorn SC. Next-generation cancer organoids. Nat Mater.
124. Kupfer ME, Lin WH, Ravikumar V, et al. In situ expansion,
differentiation, and electromechanical coupling of human 2022;21:143-159.
cardiac muscle in a 3D bioprinted, chambered organoid. doi: 10.1038/s41563-021-01057-5
Circulation Res. 2020;127:207-224.
136. Lawlor KT, Vanslambrouck JM, Higgins JW. Cellular
doi: 10.1161/CIRCRESAHA.119.316155 extrusion bioprinting improves kidney organoid
125. Hu N, Shi JX, Chen C, et al. Constructing organoid-brain- reproducibility and conformation. Nat Mater. 2021;20:
computer interfaces for neurofunctional repair after brain 260-271.
injury. Nat Commun. 2024;15:9580. doi: 10.1038/s41563-020-00853-9
doi: 10.1038/s41467-024-53858-2 137. Schuster B, Junkin M, Kashaf SS, et al. Automated
126. Li Y, Yang L, Hou Y, et al. Polydopamine-mediated graphene microfluidic platform for dynamic and combinatorial drug
oxide and nanohydroxyapatite-incorporated conductive screening of tumor organoids. Nat Commun. 2020;11:5271.
scaffold with an immunomodulatory ability accelerates doi: 10.1038/s41467-020-19058-4
periodontal bone regeneration in diabetes. Bioact Mater.
2022;18:213-227. 138. Brandenberg N, Hoehnel S, Kuttler F, et al. High-throughput
automated organoid culture via stem-cell aggregation in
doi: 10.1016/j.bioactmat.2022.03.021 microcavity arrays. Nat Biomed Eng. 2020;4:863-874.
127. Zhang Q, He J, Zhu D, et al. Genetically modified organoids doi: 10.1038/s41551-020-0565-2
for tissue engineering and regenerative medicine. Adv
Colloid and Interface Sci. 2024;335:103337. 139. Zhang Y, Li G, Wang J, Zhou F, Ren X, Su J, et al. Small
joint organoids 3D bioprinting: Construction strategy and
doi: 10.1016/j.cis.2024.103337
application. Small. 2024;20:e2302506.
128. Sugimoto S, Kobayashi E, Fujii M, et al. An organoid-based doi: 10.1002/smll.202302506
organ-repurposing approach to treat short bowel syndrome.
Nature. 2021;592:99-104. 140. Velasco V, Shariati SA, Esfandyarpour R. Microtechnology-
based methods for organoid models. Microsyst Nanoeng.
doi: 10.1038/s41586-021-03247-2
2020;6:76.
129. Corsini NS, Knoblich JA. Human organoids: New strategies doi: 10.1038/s41378-020-00185-3
and methods for analyzing human development and disease.
Cell. 2022;185:2756-2769. 141. Andrews MG, Kriegstein AR. Challenges of organoid
research. Ann Rev Neurosci. 2022;45:23-39.
doi: 10.1016/j.cell.2022.06.051
doi: 10.1146/annurev-neuro-111020-090812
130. Cerneckis J, Bu G, Shi Y. Pushing the boundaries of brain
organoids to study Alzheimer’s disease. Trends Mol Med. 142. Chen Z, Sugimura R, Zhang YS, Ruan C, Wen C. Organoids
2023;29:659-672. in concert: Engineering in vitro models toward enhanced
doi: 10.1016/j.molmed.2023.05.007 fidelity. Aggregate. 2024;5:e478.
131. Smits LM, Reinhardt L, Reinhardt P, et al. Modeling doi: 10.1002/agt2.478
Parkinson’s disease in midbrain-like organoids. NPJ 143. Shirure VS, Hughes CC, George SC. Engineering
Parkinsons Dis. 2019;5:5. vascularized organoid-on-a-chip models. Ann Rev Biomed
doi: 10.1038/s41531-019-0078-4 Eng. 2021;23:141-167.
132. Dekkers JF, Wiegerinck CL, De Jonge HR, et al. A functional doi: 10.1146/annurev-bioeng-090120-094330
CFTR assay using primary cystic fibrosis intestinal organoids. 144. Neal JT, Li X, Zhu J, et al. Organoid modeling of the tumor
Nat Med. 2013;19:939-945. immune microenvironment. Cell. 2018;175:1972-1988.
doi: 10.1038/nm.3201 e1916.
133. Chan LL, Anderson DE, Cheng HS, et al. The establishment doi: 10.1016/j.cell.2018.11.021
of COPD organoids to study host-pathogen interaction 145. Schuth S, Le Blanc S, Krieger TG, et al. Patient-specific
reveals enhanced viral fitness of SARS-CoV-2 in bronchi. modeling of stroma-mediated chemoresistance of pancreatic
Nat Commun. 2022;13:7635. cancer using a three-dimensional organoid-fibroblast
doi: 10.1038/s41467-022-35253-x co-culture system. J Exp Clin Cancer Res. 2022;41:312.
134. Puca L, Bareja R, Prandi D, et al. Patient derived organoids doi: 10.1186/s13046-022-02519-7
to model rare prostate cancer phenotypes. Nat Commun. 146. Mota C, Camarero-Espinosa S, Baker MB, Wieringa P,
2404;9:2404.
Moroni L. Bioprinting: From tissue and organ development
doi: 10.1038/s41467-018-04495-z to in vitro models. Chem Rev. 2020;120:10547-10607.

Volume 1 Issue 1 (2025) 18 doi: 10.36922/OR025040007